Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
Chubb
Julphar
Farmers Insurance
Boehringer Ingelheim
Healthtrust
McKinsey
Daiichi Sankyo

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070533

« Back to Dashboard

NDA 070533 describes PROLIXIN, which is a drug marketed by Apothecon and Bristol Myers Squibb and is included in five NDAs. Additional details are available on the PROLIXIN profile page.

The generic ingredient in PROLIXIN is fluphenazine enanthate. There are eighteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.
Summary for 070533
Tradename:PROLIXIN
Applicant:Apothecon
Ingredient:fluphenazine hydrochloride
Patents:0
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CONCENTRATE;ORALStrength5MG/ML
Approval Date:Nov 7, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Farmers Insurance
Baxter
UBS
Argus Health
Mallinckrodt
Teva
Express Scripts
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.